pharma industry

Bayer to Spend $1 Billion on US Drug R&D

Bayer is looking to spend $1 billion on drug research and development in the United States during 2023 as part of a plan to double its sales in the country by the end of the decade.

Sanofi Joins Pfizer in nonprofit Drug Distribution

Two globally oriented drugmakers, Pfizer and Sanofi, are making moves that some may interpret as attempts to allay the pharma industry‘s reputation for being “only in it for the money” but could potentially benefit poorer countries if all goes to plan.

Deck of “Trump Cards” Collapses Pharma Deal

After a roller coaster ride entailing months of on again-off again negotiations with US president Donald Trump over drug prices, the country’s pharmaceutical industry is licking its wounds and gearing up for a fight.

Analyzing Pores Deep-down

MENA Pharmaceutical Market

Evolution of Technology

The Biggest Side-Effect of Making Medicine

Leaving the Patent Cliff Behind

Pharma Players Mostly Lift 2015 Guidance

Significant Value Creation

Quality and Efficiency in Pharma Manufacturing

Drugs Industry Battered by Currency and Competition

International Drugmakers Meet Challenges

DSM to Fold Pharma Arm into Venture with Private Equity Firm

Swiss Visionary

GlaxoSmithKline Set for Human Genome Takeover

After Roche Merger, Biotech Tail Wags Big Pharma Dog

GSK Again Extends its $2.6 Billion Human Genome Offer

China Pharmaceutical Says to Buy $1.16 Billion Assets from Parent

7 Steps to GMP Compliance

What Pharma Can Learn from the Tobacco Industry

AstraZeneca to Cut 400 U.S. Jobs

Porsche Consulting on Lessons from the Auto Industry